1. Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial1. Issue 7 (10th February 2014) Authors: Lake, JE; McComsey, GA; Hulgan, T; Wanke, CA; Mangili, A; Walmsley, SL; Stramotas, SA; Tracy, R; Currier, JS Journal: HIV medicine Issue: Volume 15:Issue 7(2014:Aug.) Page Start: 431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗